The changing role of radiation in the post-TME ERA of rectal cancer

Lily L. Lai, Charles R. Thomas

Research output: Contribution to journalReview articlepeer-review


Total mesorectal excision (TME) for rectal cancer is now considered standard in the surgical treatment of rectal cancer. The application of this technique has resulted in a pooled pelvic recurrence rate of approximately 7%. Preoperative and postoperative radiation further decreases the local regional recurrence (LRR) rate in patients with rectal cancer but the reduction in risk is counterbalanced by increased short and long term toxicity. Lower LRR rates have not uniformly translated into more favorable overall survival. In addition, advances in imaging have resulted in more accurate pretreatment staging and have improved the ability to stratify patients based on risk of recurrence. Given low pelvic recurrence rates after TME-based surgery alone, the risks and toxicities of pelvic radiation, and superior imaging to select high risk patients, radiation may not be requisite in the treatment of all rectal cancer patients. In this review, we discuss the current status of radiation and LRR rates in rectal cancer after definitive surgical resection with respect to specific subsites and stages of disease, examine the impact of imaging in the selection of patients for radiation, and raise the possibility that predictive biomarkers may help to identify patients who may not require pelvic radiation.

Original languageEnglish (US)
Pages (from-to)243-248
Number of pages6
JournalCurrent Cancer Therapy Reviews
Issue number3
StatePublished - 2010


  • Chemoradiation
  • Local recurrence rates
  • Rectal cancer
  • Total mesorectal excision

ASJC Scopus subject areas

  • Molecular Medicine
  • Oncology
  • Cancer Research


Dive into the research topics of 'The changing role of radiation in the post-TME ERA of rectal cancer'. Together they form a unique fingerprint.

Cite this